Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Total Non-Current Liabilities: 2019-2021

Historic Total Non-Current Liabilities for ENDRA Life Sciences (NDRA) over the last 1 years, with Mar 2021 value amounting to $280,829.

  • ENDRA Life Sciences' Total Non-Current Liabilities fell 13.80% to $280,829 in Q1 2021 from the same period last year, while for Mar 2021 it was $280,829, marking a year-over-year decrease of 13.80%. This contributed to the annual value of $608,992 for FY2020, which is 77.65% up from last year.
  • ENDRA Life Sciences' Total Non-Current Liabilities amounted to $280,829 in Q1 2021, which was down 53.89% from $608,992 recorded in Q4 2020.
  • In the past 5 years, ENDRA Life Sciences' Total Non-Current Liabilities registered a high of $645,450 during Q2 2020, and its lowest value of $280,829 during Q1 2021.
  • For the 3-year period, ENDRA Life Sciences' Total Non-Current Liabilities averaged around $455,768, with its median value being $358,915 (2019).
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first surged by 77.65% in 2020, then decreased by 13.80% in 2021.
  • Over the past 3 years, ENDRA Life Sciences' Total Non-Current Liabilities (Quarterly) stood at $342,812 in 2019, then spiked by 77.65% to $608,992 in 2020, then decreased by 13.80% to $280,829 in 2021.
  • Its Total Non-Current Liabilities stands at $280,829 for Q1 2021, versus $608,992 for Q4 2020 and $627,573 for Q3 2020.